Evidence map›Paper›PMID 28716901›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface.

Patrick J Brennan, Tan-Yun Cheng, Daniel G Pellicci, Gerald F M Watts, Natacha Veerapen, David C Young, Jamie Rossjohn, Gurdyal S Besra, Dale I Godfrey, Michael B Brenner and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Sideways lipid presentation by the antigen-presenting molecule CD1c.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Lipidomic scanning of self-lipids identifies headless antigens for natural killer T cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Article
  8. Serine-/Cysteine-Based spJournal of medicinal chemistry · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. NKT Cells Contribute to the Control of Microbial Infections.Frontiers in cellular and infection microbiology · 2021
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Patrick J BrennanDepartment of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; pbrennan3@bwh.harvard.edu mbrenner@research.bwh.harvard.edu bmoody@bwh.harvard.edu.
Tan-Yun ChengDepartment of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Daniel G PellicciDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC 3010, Australia.
Gerald F M WattsDepartment of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Natacha VeerapenSchool of Biosciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.
David C YoungDepartment of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Jamie RossjohnInfection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia.
Gurdyal S BesraSchool of Biosciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.
Dale I GodfreyDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC 3010, Australia.
Michael B BrennerDepartment of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; pbrennan3@bwh.harvard.edu mbrenner@research.bwh.harvard.edu bmoody@bwh.harvard.edu.
D Branch MoodyDepartment of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; pbrennan3@bwh.harvard.edu mbrenner@research.bwh.harvard.edu bmoody@bwh.harvard.edu.
Harvard University · USUniversity of Birmingham · GBAustralian Research Council · AUBrigham and Women's Hospital · USMonash University · AUPeter Doherty Institute · AU

Funding

Metabolomics Core U19AI111224 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH, MURRAY, MEGAN B · 2015 to 2021
$20.4M
CD1 Presentation of Self Lipids to Human T CellsR01AR048632 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI MOODY, DAVID BRANCH · 2002 to 2024
$9.4M
CD1d-restricted T Cell Self-antigens and InfectionR01AI063428 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2005 to 2015
$3.9M
Regulatory iNKT Cells Suppress Inflammation and Drive ThermogenesisR01AI113046 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2014 to 2023
$3.9M
CD1 autoreactive T cells in human inflammatory skin diseaseR37AR048632 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI DAVID Branch MOODY · 2025 to 2026
$1.1M
Self and dietary lipid antigens for invariant natural killer T cellsK08AI102945 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNAN, PATRICK JOSEPH · 2013 to 2016
$736k
CD1d and NKT Cell Activation and Function in InfectionR56AI063428 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BRENNER, MICHAEL B. · 2010 to 2010
$433k
Medical Research CouncilNIAID NIH HHS K08 AI102945NIAID NIH HHS R01 AI063428NIAID NIH HHS R01 AI113046NIAID NIH HHS R56 AI063428NIAID NIH HHS U19 AI111224NIAMS NIH HHS R01 AR048632NIAMS NIH HHS R37 AR048632
6 · The paper itself

Abstract

Glycolipid antigens recognized by αβ T-cell receptors (TCRs) drive the activation of invariant natural killer T (iNKT) cells, a specialized subset of innate T lymphocytes. Glycolipids with α-linked anomeric carbohydrates have been identified as potent microbial lipid antigens for iNKT cells, and their unusual α-anomeric linkage has been thought to define a "foreign" lipid antigen motif. However, mammals use endogenous lipids to select iNKT cells, and there is compelling evidence for iNKT cell responses in various types of sterile inflammation. The nature of endogenous or environmental lipid antigens encountered by iNKT cells is not well defined. Here, we sought to identify lipid antigens in cow's milk, a prominent part of the human diet. We developed a method to directly capture lipid antigens within CD1d-lipid-TCR complexes, while excluding CD1d bound to nonantigenic lipids, followed by direct biochemical analysis of the lipid antigens trapped at the TCR-CD1d interface. The specific antigens captured by this "TCR trap" method were identified as α-linked monohexosylceramides by mass spectrometry fragmentation patterns that distinguished α- from β-anomeric monohexosylceramides. These data provide direct biochemical evidence for α-linked lipid antigens from a common dietary source.

Indexed as

AnimalsAntigens, CD1dBiological AssayDietGalactosylceramidesHumansLymphocyte ActivationMiceMilkNatural Killer T-CellsReceptors, Antigen, T-Cell, alpha-betaSpectrometry, Mass, Electrospray IonizationAntigens, CD1dCD1d antigen, mouseGalactosylceramidesReceptors, Antigen, T-Cell, alpha-betaCD1dglycolipidiNKTlipid antigenNKT

Identifiers

PMID28716901
PMCPMC5547638
OpenAlexW2734395944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.